Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer.
Vairaktaris E, Yapijakis C, Serefoglou Z, Vylliotis A, Ries J, Nkenke E, Wiltfang J, Derka S, Vassiliou S, Springer I, Kessler P, Neukam FW.
Vairaktaris E, et al. Among authors: ries j.
Oral Oncol. 2006 Oct;42(9):888-92. doi: 10.1016/j.oraloncology.2005.12.005. Epub 2006 May 26.
Oral Oncol. 2006.
PMID: 16730474